Two-bag intravenous N-acetylcysteine, antihistamine pretreatment and high plasma paracetamol levels are associated with a lower incidence of anaphylactoid reactions to N-acetylcysteine.

MLA

Daoud, Alaa, et al. “Two-Bag Intravenous N-Acetylcysteine, Antihistamine Pretreatment and High Plasma Paracetamol Levels Are Associated with a Lower Incidence of Anaphylactoid Reactions to N-Acetylcysteine.” Clinical Toxicology (Philadelphia, Pa.), vol. 58, no. 7, July 2020, pp. 698–704. EBSCOhost, https://doi.org/10.1080/15563650.2019.1675886.

APA

Daoud, A., Dalhoff, K. P., Christensen, M. B., Bøgevig, S., & Petersen, T. S. (2020). Two-bag intravenous N-acetylcysteine, antihistamine pretreatment and high plasma paracetamol levels are associated with a lower incidence of anaphylactoid reactions to N-acetylcysteine. Clinical Toxicology (Philadelphia, Pa.), 58(7), 698–704. https://doi.org/10.1080/15563650.2019.1675886

Chicago

Daoud, Alaa, Kim Peder Dalhoff, Mikkel Bring Christensen, Søren Bøgevig, and Tonny Studsgaard Petersen. 2020. “Two-Bag Intravenous N-Acetylcysteine, Antihistamine Pretreatment and High Plasma Paracetamol Levels Are Associated with a Lower Incidence of Anaphylactoid Reactions to N-Acetylcysteine.” Clinical Toxicology (Philadelphia, Pa.) 58 (7): 698–704. doi:10.1080/15563650.2019.1675886.